LIDOCAINE HYDROCHLO

The contract awarded to DMS PHARMACEUTICAL GROUP INC under solicitation SPE2DP26F7794 is a firm-fixed-price delivery order valued at $86.95, issued under the base contract SPE2DX25D9900 by the Defense Logistics Agency through DLA Troop Support. The sole line item specifies the delivery of five packs of lidocaine hydrochloride, identified by NSN 6505015865691, at a unit price of $17.39, with no variance allowed in quantity. Delivery is mandated for July 20, 2026, to Fort Bragg, North Carolina, under FOB destination terms, meaning the contractor assumes all costs and risks until the goods are received at the destination. Inspection and acceptance occur at the delivery point by the government, and shipments must be sent via traceable means with parcel post strictly prohibited. Invoicing must comply with DFARS 252.232-7003, requiring electronic submission through WAWF, and payments will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, under accounting code 97X4930 5CBX 001 2620 S33189. The contractor is certified as a small, small disadvantaged, and women-owned business, triggering associated reporting obligations under FAR 19.7, 19.14, and 19.15. The contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena. No additional clauses, attachments, or evaluation factors are included in the documentation, and all terms are referenced primarily through the underlying basic contract. Packaging, labeling, and technical specifications are not fully detailed but are implied to align with standard DoD logistics and pharmaceutical handling protocols.